So the key catalyst will be the P3 OA top line readout, potentially around October 2024, and only if the FDA allow us to up the dose to 2mg/kg, making the meeting with the FDA another key catalyst. It is possible regional deals could be struck prior to this readout given that potential partners may want to lock in a deal beforehand or risk having to pay more if the top line readout is a smashing success. PAR should have enough data to secure an upfront payment prior to the top line readout.
- Forums
- ASX - By Stock
- Ann: PAR Successful Placement and Fully Underwritten ANREO
So the key catalyst will be the P3 OA top line readout,...
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M |
Open | High | Low | Value | Volume |
22.0¢ | 23.5¢ | 22.0¢ | $66.95K | 294.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 90092 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 25858 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 90092 | 0.220 |
7 | 93958 | 0.215 |
7 | 143016 | 0.210 |
4 | 104982 | 0.205 |
6 | 89975 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 25858 | 1 |
0.240 | 40833 | 1 |
0.245 | 37318 | 1 |
0.250 | 15000 | 1 |
0.255 | 9785 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |